McCulloch Kevin
McCulloch Kevin, SR, reported a transaction classified as withholding at Xeris Biopharma Holdings, Inc. involving 21918.000000 shares for an estimated $177097.44. Reported holdings after the transaction were 1654208.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 01, 2026
- Filing date
- Aug 21, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingXERS price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- withholding Code F
- Identifier
- 0001867096-26-000069 Common Stock
- Transaction date
- Aug 01, 2026 Filed Aug 21, 2026, 08:15 PM · 20d delay
- Shares
- 21,918 sh $8.08 per share
- Estimated value
- -$177k Computed from shares × price
- Holdings after
- 1,654,208 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-22 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tax_withholding-22 points
transaction_code = F
Tax withholding on vesting shares is mechanical. - delayed_filing-6 points
reporting_delay_days = 20
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
See Remarks
- F1
Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as o…
- F2
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an…
0 other transactions
0 recent txs